| Product Code: ETC9962021 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Celiac Drugs Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Celiac Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Celiac Drugs Market - Industry Life Cycle |
3.4 United States (US) Celiac Drugs Market - Porter's Five Forces |
3.5 United States (US) Celiac Drugs Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Celiac Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 United States (US) Celiac Drugs Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Celiac Drugs Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Celiac Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Celiac Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of celiac disease in the US |
4.2.2 Growing demand for gluten-free products and diets |
4.2.3 Advancements in drug development for celiac disease treatment |
4.2.4 Favorable regulatory environment supporting celiac drug approvals |
4.2.5 Rising prevalence of autoimmune disorders contributing to the market growth |
4.3 Market Restraints |
4.3.1 Limited availability of effective celiac drugs in the market |
4.3.2 High costs associated with celiac drug development and treatment |
4.3.3 Challenges in accurate diagnosis and monitoring of celiac disease |
4.3.4 Lack of universal gluten-free labeling regulations |
4.3.5 Potential side effects and safety concerns related to celiac drugs |
5 United States (US) Celiac Drugs Market Trends |
6 United States (US) Celiac Drugs Market, By Types |
6.1 United States (US) Celiac Drugs Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Celiac Drugs Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Celiac Drugs Market Revenues & Volume, By Biological Drugs, 2021- 2031F |
6.1.4 United States (US) Celiac Drugs Market Revenues & Volume, By Immunosuppresants, 2021- 2031F |
6.1.5 United States (US) Celiac Drugs Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.1.6 United States (US) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Celiac Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Celiac Drugs Market Revenues & Volume, By Classical Celiac Disease, 2021- 2031F |
6.2.3 United States (US) Celiac Drugs Market Revenues & Volume, By Non- Classical Celiac Disease, 2021- 2031F |
6.2.4 United States (US) Celiac Drugs Market Revenues & Volume, By Silent Celiac Disease, 2021- 2031F |
6.3 United States (US) Celiac Drugs Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Celiac Drugs Market Revenues & Volume, By Topical, 2021- 2031F |
6.3.3 United States (US) Celiac Drugs Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Celiac Drugs Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.5 United States (US) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Celiac Drugs Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Celiac Drugs Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Celiac Drugs Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.4 United States (US) Celiac Drugs Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
6.4.5 United States (US) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Celiac Drugs Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Celiac Drugs Market Revenues & Volume, By Direct Tender, 2021- 2031F |
6.5.3 United States (US) Celiac Drugs Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.4 United States (US) Celiac Drugs Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.5.5 United States (US) Celiac Drugs Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.6 United States (US) Celiac Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Celiac Drugs Market Import-Export Trade Statistics |
7.1 United States (US) Celiac Drugs Market Export to Major Countries |
7.2 United States (US) Celiac Drugs Market Imports from Major Countries |
8 United States (US) Celiac Drugs Market Key Performance Indicators |
8.1 Patient adherence rate to celiac drug therapy |
8.2 Number of clinical trials and research studies in the celiac drug market |
8.3 Rate of adoption of gluten-free diets in the US population |
8.4 Percentage of healthcare professionals trained in celiac disease management |
8.5 Patient-reported outcomes and quality of life improvements with celiac drug therapy |
9 United States (US) Celiac Drugs Market - Opportunity Assessment |
9.1 United States (US) Celiac Drugs Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Celiac Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 United States (US) Celiac Drugs Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Celiac Drugs Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Celiac Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Celiac Drugs Market - Competitive Landscape |
10.1 United States (US) Celiac Drugs Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Celiac Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here